WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

Johnson & Johnson (JNJ) Stock Analysis

OW

JNJ Equity Research — OVERWEIGHT — July 2026

← ISRGLLY →

Rating date

Jul 20, 2026

21 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

17p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · JNJ

Now I have a comprehensive picture. Let me compile the analysis.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • The primary trend is bullish. JNJ is up ~58% over the past year with golden-crossed moving averages rising in unison. Long-term positioning remains favorable.
  • Short-term momentum has rolled over. The bearish MACD crossover and RSI retreat from overbought to neutral argue for caution on the immediate horizon.
  • Price is testing the Bollinger middle band (~$253), a common battleground between bulls and bears. A decisive close above $255 would reassert strength; a breakdown below $247 (recent swing low) would suggest a deeper correction.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

JNJ Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

29 min read

WebserviceX · Agentic Research Desk

JNJ Equity Research Note

Published Jul 20, 2026 · Desk view OVERWEIGHT · Generated 2026-07-21T15:40:59Z · Maintained by Walter Vijayakumar · Methodology · Track record

JNJ Stock Rating Summary

JNJ bias

OVERWEIGHT

Horizon

Long-term

JNJ key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

JNJ catalyst watch

The primary trend is bullish. JNJ is up ~58% over the past year with golden-crossed moving averages rising in unison. Long-term positioning remains favorable.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 17p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:27.098922+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Awaiting market data

5D trend

-3.47%

Vol (20D ann.)

+31.40%

vs SPY: -2.53%

Close 248.82 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · JNJ

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace fe3bebef…

No QC issues recorded.